相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses
James B. Corcoran et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia
Irini Manoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats
Jun-Feng Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Catalase Deficiency Accelerates Diabetic Renal Injury Through Peroxisomal Dysfunction
Inah Hwang et al.
DIABETES (2012)
Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells
Yanggang Yuan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Chronic high glucose downregulates mitochondrial calpain 10 and contributes to renal cell death and diabetes-induced renal injury
Marisa D. Covington et al.
KIDNEY INTERNATIONAL (2012)
Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis
Ivica Grgic et al.
KIDNEY INTERNATIONAL (2012)
Tubulointerstitial injury and the progression of chronic kidney disease
Kavita S. Hodgkins et al.
PEDIATRIC NEPHROLOGY (2012)
Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal Disease
Gabriella Casalena et al.
SEMINARS IN NEPHROLOGY (2012)
Pirfenidone for Diabetic Nephropathy
Kumar Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Mitochondria-Targeted Peptide Accelerates ATP Recovery and Reduces Ischemic Kidney Injury
Hazel H. Szeto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis
Daryl M. Okamura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Renoprotective properties of pirfenidone in subtotally nephrectomized rats
Koji Takakuta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
PKC-δ Promotes Renal Tubular Cell Apoptosis Associated with Proteinuria
Xiaoning Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The Role of Mitochondria in Apoptosis
Chunxin Wang et al.
ANNUAL REVIEW OF GENETICS (2009)
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease
Simona Granata et al.
BMC GENOMICS (2009)
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats
Matthias Schaier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy
Stephanie Kraemer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells
Marie-Luise Brezniceanu et al.
DIABETES (2008)
From mitochondria to disease: Role of the renin-angiotensin system
E. M. V. de Cavanagh et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
A pilot study in patients with established advanced liver fibrosis using pirfenidone
J. Armendariz-Borunda et al.
GUT (2006)
Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction
NG Docherty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Progression in chronic kidney disease
AA Eddy
ADVANCES IN CHRONIC KIDNEY DISEASE (2005)
Effect of pirfenidone on apoptosis-regulatory genes in chronic cyclosporine nephrotoxicity
FS Shihab et al.
TRANSPLANTATION (2005)
A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis
JE Walker et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
分享论文
